In some embodiments, the formulations described herein have a pH and/or practical osmolarity as described herein, and have a concentration of active pharmaceutical ingredient from about 0.0001% to about 60%, from about 0.001% to about 40%, from about 0.01% to about 20%, from about 0.01% to about 10%, from about 0.01% to about 7.5%, from about 0.01% to about 6%, from about 0.01 to about 5%, from about 0.1 to about 10%, or from about 0.1 to about 6% of the active ingredient by weight of the formulation
These two peptides target overlapping but distinct stages of the tissue repair process, making their combination more effective than either used alone
Ingredients: S-Acetyl-L-Glutathione Other ingredients: microcrystalline cellulose, capsule shell hydroxypropyl methyl cellulose * % Nutrient Reference Value (NRV) according to the regulation EU 1169/2011 ** No Reference Value available Warnings: The stated recommended daily dose should not be exceeded
Lipoic acid might be able to increase glutathione synthesis in aged rats by up-regulating the expression of -glutamylcysteine ligase (-GCL), the rate-limiting enzyme in glutathione synthesis (31), and by increasing cellular uptake of cysteine, an amino acid required for glutathione synthesis (32)
Rather, it recognizes that LDL-C is one important measure within a broader framework of cardiovascular risk assessment